In that regard, Peruvian HCC forgoes some of the canonical hallmarks of the proliferative class (e.g., IGF2, Notch, Ras/MAPK, and TGF-β) [3, 4]. The gene discussed is IGF2; the disease is hepatocellular carcinoma.